The Assisted Reproductive Technology market is experiencing substantial growth, with a projected value of $37.21 billion in 2025 and a compound annual growth rate of 8.3%. Factors driving this growth include increasing infertility rates, changing societal norms, and legislative support. The market is expected to reach $52.84 billion by 2029, with trends such as the use of artificial intelligence, egg freezing, and genetic screening shaping the industry.
One significant driver of growth is the rising prevalence of infertility cases, affecting approximately 1 in 6 adults globally. Another key factor is the escalating prevalence of obesity, which may impact fertility rates and increase the demand for specialized ART services. Leading companies are developing innovative products, such as DNA sequencing-based options for preimplantation genetic testing, to enhance success rates in IVF procedures.
In a recent acquisition, CooperCompanies acquired Cook Medical’s Reproductive Health business for $300 million, strengthening its position in the fertility and women’s health sectors. The market encompasses various segments such as diagnosis, procedure type, and end-users, with key players including Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., and Thermo Fisher Scientific Inc.
Overall, the Assisted Reproductive Technology market is projected to experience significant growth in the coming years, driven by technological advancements, increasing demand for fertility treatments, and strategic acquisitions within the industry. Market research firm ResearchAndMarkets.com provides valuable insights and data on international and regional markets, key industries, top companies, new products, and emerging trends in the sector.
Source
Photo credit www.globenewswire.com